Wuhan YZY Biopharma Co Ltd

NEW
HKSE:02496 (China)   Ordinary Shares - Class H
HK$ 3.6 (0%) Aug 21
At Loss
Market Cap:
HK$ 697.86M ($ 89.00M)
Enterprise V:
HK$ 730.12M ($ 93.11M)
Volume:
0
Avg Vol (2M):
1.90K
Trade In:

Wuhan YZY Biopharma Co Ltd (HKSE:02496) Dividend

Wuhan YZY Biopharma Co Ltd (HKSE:02496) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -0.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: HKSE:02496 Dividend

Does Wuhan YZY Biopharma Co Ltd (HKSE:02496) pay a dividend?

Wuhan YZY Biopharma Co Ltd (HKSE:02496) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Wuhan YZY Biopharma Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Wuhan YZY Biopharma Co Ltd has returned capital to shareholders via buybacks at a rate of -0.1% over the past 3 years.

What are dividend-paying alternatives to Wuhan YZY Biopharma Co Ltd?

For dividend-paying alternatives in Wuhan YZY Biopharma Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.